Concepedia

Manoj Samant

MS

Statistics

Publications

12

Citations

399

H-Index

12

Active since

2001

Affiliations

Salk Institute for Biological Studies(Current)

General Atomics (United States)

Clayton Foundation

University Medical Center Groningen

University of Bern

Manoj Samant is an author at Salk Institute for Biological Studies specializing in pharmacology, medicinal chemistry, and drug discovery.

Publications per year

2001–2024

12

Publications

12

Efficacy and safety of mavrilimumab in giant cell arteritis: a phase 2, randomised, double-blind, placebo-controlled trial

María C. Cid, Sebastian Unizony, Daniël Blockmans et al. · Annals of the Rheumatic Diseases · 2022 · 122 citations · Full text

, , +14

Synergistic metabolic benefits of an exenatide analogue and cholecystokinin in diet‐induced obese and leptin‐deficient rodents

James L. Trevaskis, Changqi Sun, Jennifer Athanacio et al. · Diabetes Obesity and Metabolism · 2014 · 59 citations

, , +17

Novel Exenatide Analogs with Peptidic Albumin Binding Domains: Potent Anti-Diabetic Agents with Extended Duration of Action

Odile E. Levy, Carolyn M. Jodka, Shijun Steven Ren et al. · PLoS ONE · 2014 · 47 citations · Full text

, , +17

Self-Assembling, Cystine-Derived, Fused Nanotubes Based on Spirane Architecture:  Design, Synthesis, and Crystal Structure of Cystinospiranes

Darshan Ranganathan, Manoj Samant, Isabella L. Karle · Journal of the American Chemical Society · 2001 · 28 citations

, , +17

Ring Size of Somatostatin Analogues (ODT-8) Modulates Receptor Selectivity and Binding Affinity

Judit Érchegyi, Christy R. Grace, Manoj Samant et al. · Journal of Medicinal Chemistry · 2008 · 27 citations · Full text

, , +14

1–5 of 12